mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.3 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.3 |
mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.3 |
mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.3 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |